Takano (7885) · InitiativeAchieved
Preparations for New Entry into the In Vitro Diagnostic Products Market
First written in FY2024-Q1. 1 of 2 entries say "Achieved", first in FY2024. Latest entry: FY2024.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Entry into the In Vitro Diagnostics BusinessA theme 2 companies write about · 0 as a headwind · 2 as a tailwind
0 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024AchievedAnnual report
「In the clinical laboratory testing products business, which the company had worked on for many years as a new business area, it was able to begin sales in November 2023.」
Preparations to enter the in-vitro diagnostic products and clinical laboratory testing products markets progressed to the launch of sales in November 2023. - FY2024-Q1First statedAnnual report
「While focusing on the development and production of office furniture that creates new value for offices in response to changes in the way people work, the company proceeded with preparations to enter the in-vitro diagnostic products market.」
The company disclosed for the first time specific preparations to enter the in-vitro diagnostic products market as a new business. Expenses related to the new business were reclassified to the residential and lifestyle-related equipment segment because commercialization had become foreseeable.